as 06-12-2025 4:00pm EST
Stocks
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Founded: | 2009 | Country: | United States |
Employees: | N/A | City: | NATICK |
Market Cap: | 22.8M | IPO Year: | N/A |
Target Price: | $22.83 | AVG Volume (30 days): | 320.5K |
Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -5.10 | EPS Growth: | N/A |
52 Week Low/High: | $2.15 - $88.75 | Next Earning Date: | 08-12-2025 |
Revenue: | $28,304,000 | Revenue Growth: | -41.98% |
Revenue Growth (this year): | -7.96% | Revenue Growth (next year): | 49.35% |
ALUR Breaking Stock News: Dive into ALUR Ticker-Specific Updates for Smart Investing
GOBankingRates
12 days ago
GOBankingRates
12 days ago
GOBankingRates
12 days ago
Yahoo Finance
12 days ago
The Guardian
12 days ago
Yahoo Finance Video
12 days ago
Benzinga
12 days ago
Reuters
12 days ago
The information presented on this page, "ALUR Allurion Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.